These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16105024

  • 1. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.
    Vernon HJ, Osborne C, Tzortzaki EG, Yang M, Chen J, Rittling SR, Denhardt DT, Buyske S, Bledsoe SB, Evan AP, Fairbanks L, Simmonds HA, Tischfield JA, Sahota A.
    Kidney Int; 2005 Sep; 68(3):938-47. PubMed ID: 16105024
    [Abstract] [Full Text] [Related]

  • 2. Sequential analysis of kidney stone formation in the Aprt knockout mouse.
    Evan AP, Bledsoe SB, Connors BA, Deng L, Liang L, Shao C, Fineberg NS, Grynpas MD, Stambrook PJ, Youzhi S, Sahota A, Tischfield JA.
    Kidney Int; 2001 Sep; 60(3):910-23. PubMed ID: 11532086
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L, Liaw L, Evan AP, Sommer AJ, Lieske JC, Wu XR.
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [Abstract] [Full Text] [Related]

  • 12. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone.
    Umekawa T, Kohri K, Kurita T, Hirota S, Nomura S, Kitamura Y.
    Biochem Mol Biol Int; 1995 Jan; 35(1):223-30. PubMed ID: 7735136
    [Abstract] [Full Text] [Related]

  • 13. Effects of cyclosporine in osteopontin null mice.
    Mazzali M, Hughes J, Dantas M, Liaw L, Steitz S, Alpers CE, Pichler RH, Lan HY, Giachelli CM, Shankland SJ, Couser WG, Johnson RJ.
    Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of female sex hormones on urinary stone formation in rats.
    Iguchi M, Takamura C, Umekawa T, Kurita T, Kohri K.
    Kidney Int; 1999 Aug; 56(2):479-85. PubMed ID: 10432386
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
    Langdon A, Grohe B.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():296-306. PubMed ID: 27362921
    [Abstract] [Full Text] [Related]

  • 19. Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN transgenic and OPN knockout mice.
    Hamamoto S, Nomura S, Yasui T, Okada A, Hirose M, Shimizu H, Itoh Y, Tozawa K, Kohri K.
    J Bone Miner Res; 2010 Dec 01; 25(12):2712-23. PubMed ID: 19453257
    [Abstract] [Full Text] [Related]

  • 20. Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease.
    Tzortzaki EG, Yang M, Glass D, Deng L, Evan AP, Bledsoe SB, Stambrook PJ, Sahota A, Tischfield JA.
    Urol Res; 2003 Aug 01; 31(4):257-61. PubMed ID: 12856169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.